Sterile Medical Device: Class I Sterile Conformity Assessment, System and Procedure Pack Sterilization, Sterile Packaging Labelling and ÜTS Sterile Fields

SUMMARY
A sterile device is subject to separate provisions in the Medical Device Regulation: for class I devices placed on the market in a sterile condition, the notified body is involved in aspects relating to establishing, securing and maintaining sterile conditions, and Annex I lists the requirements for sterile design, manufacture, packaging and labelling.
In this article we give, with verbatim quotations (unofficial translation), the provisions of Art. 52 (6), Art. 22 (3)-(4), Annex I 11, 23.2 and 23.3, and the sterility fields in the TİTCK ÜTS Registration Guidance TCKKD-KLVZ-03.
For ÜTS registration of your medical device: Medical Device ÜTS Registration Consultancy
Contents
1. Sterile Class I Device: Art. 52 (6)
2. The Person Who Sterilizes a System or Procedure Pack: Art. 22
3. Annex I 11: Requirements for Sterile Devices
4. Sterilization in the Technical Documentation: Annex II
5. Label and Sterile Packaging Information: Annex I 23
6. Distributor or Importer Repackaging a Sterile Device
7. Sterility Fields in the ÜTS Record
8. Frequently Asked Questions
1. Sterile Class I Device: Art. 52 (6)
“(6) With the exception of custom-made or investigational devices, manufacturers of class I devices declare the conformity of their products by issuing the EU declaration of conformity referred to in Article 19 after drawing up the technical documentation specified in Annex II and Annex III. If these devices are placed on the market in sterile condition, have a measuring function or are reusable surgical instruments, the manufacturer applies the procedures specified in Chapters I and III of Annex IX or in Part A of Annex XI. However, the involvement of the notified body in these procedures is limited to:”
“a) In the case of devices placed on the market in sterile condition, aspects relating to establishing, securing and maintaining sterile conditions,”
For a sterile class I device, the manufacturer issues the EU declaration of conformity and also applies the procedure of Annex IX (Chapters I and III) or Annex XI Part A. The notified body's role is limited to aspects relating to sterile conditions. Article 61 of the ÜTS Registration Guidance gives the same provision under the name "Class-Is":
“a) In the case of devices placed on the market in sterile condition (Class-Is), aspects relating to establishing, securing and maintaining sterile conditions,”
For the choice of procedure, see our article on the conformity assessment procedure, and for the class I subgroups, our article on Class I medical devices.
2. The Person Who Sterilizes a System or Procedure Pack: Art. 22
Art. 22 (3) regulates the person who sterilizes a system or procedure pack (SPP) for placing on the market:
“(3) Any natural or legal person who sterilizes the systems or procedure packs referred to in the first paragraph for the purpose of placing them on the market applies, at its choice, one of the procedures specified in Annex IX or the procedure specified in Annex XI Part A. The application of these procedures and the involvement of the notified body are limited to the aspects of the procedure relating to ensuring sterility until the sterile package is opened or damaged. The natural or legal person draws up a declaration stating that sterilization has been carried out in accordance with the manufacturer's instructions.”
“(4) Where the system or procedure pack incorporates devices that do not bear the CE marking, where the chosen combination of devices is not compatible in view of their original intended purpose, or where the sterilization has not been carried out in accordance with the manufacturer's instructions, the system or procedure pack shall be treated as a device in its own right and shall be subject to the relevant conformity assessment procedure under Article 52. The natural or legal person shall assume the obligations incumbent on manufacturers.”
If sterilization is not carried out in accordance with the manufacturer's instructions, the SPP is treated as a device in its own right and the person sterilizing assumes the manufacturer's obligations. The Regulation covers the person carrying out sterilization in these two paragraphs. For the SPP declaration and ÜTS registration, see our page on SPP and custom-made device ÜTS registration.
Article 14 of the ÜTS Registration Guidance states the same for the SPP manufacturer:
“(3) If the SPP manufacturer additionally sterilizes the SPP pack before placing it on the market, independently of the individual sterility of the products in the SPP, it applies one of the conformity assessment procedures referred to in the ninth paragraph of Article 61 of this Guidance.”
3. Annex I 11: Requirements for Sterile Devices
Annex I, item 11 of the Medical Device Regulation (Infection and microbial contamination):
“11.4. Devices delivered in a sterile state shall be designed, manufactured and packaged in accordance with appropriate procedures, to ensure that they are sterile when placed on the market and that, unless the packaging intended to maintain their sterile condition is damaged, they remain sterile, under the transport and storage conditions specified by the manufacturer, until that packaging is opened at the point of use. It shall be ensured that the integrity of this packaging is clearly evident to the final user.”
“11.5. Devices labelled as sterile shall be processed, manufactured, packaged and sterilized by means of appropriate, validated methods.”
“11.6. Devices intended to be sterilized shall be manufactured and packaged in appropriate and controlled conditions and facilities.”
“11.7. Packaging systems for non-sterile devices shall maintain the integrity and cleanliness of the product and, where the devices are to be sterilized prior to use, minimize the risk of microbial contamination; the packaging system shall be suitable taking account of the method of sterilization indicated by the manufacturer.”
“11.8. The labelling of the device shall distinguish between identical or similar devices placed on the market in both sterile and non-sterile condition in addition to the symbol used to indicate that devices are sterile.”
Under 11.8, if the same device is placed on the market in both sterile and non-sterile condition, the label distinguishes between these two devices.
4. Sterilization in the Technical Documentation: Annex II
Subparagraph (d) of Annex II, 6.2 (Additional information required in specific cases), which regulates the technical documentation:
“In the case of devices placed on the market in sterile condition, a description of the methods used for packaging, sterilization and maintenance of sterility, including validation reports. The validation report shall address bioburden testing, pyrogen testing and, if applicable, sterilant residue testing.”
5. Label and Sterile Packaging Information: Annex I 23
Annex I 23.2, information on the label:
“i) If the device is supplied sterile, an indication of its sterile state and the sterilization method,”
Annex I 23.3, information on the sterile packaging:
“a) An indication permitting the sterile packaging to be recognized as such.”
“b) A declaration that the device is in a sterile condition.”
“c) The method of sterilization.”
“ç) The name and address of the manufacturer.”
“d) A description of the device.”
“g) The month and year of manufacture.”
“h) An unambiguous indication of the time limit for using the device safely or implanting it, expressed at least in terms of year and month.”
“ı) An instruction to check the instructions for use for what to do if the sterile packaging is damaged or unintentionally opened before use.”
Annex I 23.4, information in the instructions for use:
“i) If the device is supplied sterile, instructions in the event of damage to the sterile packaging or its unintentional opening before use,”
“j) If the device is supplied non-sterile with the intention that it is sterilized before use, appropriate instructions for sterilization,”
Art. 20 (3) determines the place of the CE marking:
“(3) The CE marking shall be affixed visibly, legibly and indelibly to the device or its sterile packaging.”
For the Turkish label and instructions for use, see our article on Turkish label and instructions for use.
6. Distributor or Importer Repackaging a Sterile Device
Art. 16 (2) (b) contains the following provision for a sterile device in the case of repackaging:
“(In the case of devices placed on the market in sterile condition, if the packaging necessary to maintain the sterile condition is opened, damaged or adversely affected by repackaging, the original condition of the device is presumed to be adversely affected.)”
The other provisions of Art. 16 are in our article on distributors and importers being considered manufacturers.
7. Sterility Fields in the ÜTS Record
Article 27 of the ÜTS Registration Guidance (device record within the scope of the MDR) lists the option "Class-Is (with sterile function)" in the risk class field. The sterility fields:
“r) Packaged sterile?:”
“2) This field is selected as "Yes" if the device is placed on the market packaged sterile, and "No" if it is not packaged sterile.”
“4) If the device is packaged sterile, this information must be on the label and/or sales packaging and in the instructions for use, and this field must be selected as "Yes".”
Sterilization method field:
“3) More than one sterilization method can be selected in this field. Therefore, it is mandatory to select from the list all the sterilization methods used in packaging.”
“5) The sterilization method used in the packaging of the device (all sterilization methods, if there is more than one) must be stated on the label and/or sales packaging and in the instructions for use.”
The guidance's route for a method not in the list:
“If the sterilization method to be selected is not in this list, a request can be created for the addition of that sterilization method, using the "Medical Device Document And Product Registration Procedures" field on the "Report Request" screen in ÜTS.”
Field for sterilization before use:
“ş) Is Sterilization Required Before Use?:”
“4) If the device must be sterilized before use, this information must be in the instructions for use and this field must be selected as "Yes". This information is not required to be on the label and/or sales packaging.”
For the other fields of the record screen, see our article on ÜTS product registration.
8. Frequently Asked Questions
Is a notified body required for a sterile class I device?
Yes. Under Art. 52 (6), the manufacturer applies the procedure of Annex IX (Chapters I and III) or Annex XI Part A; the notified body's role is limited to aspects relating to establishing, securing and maintaining sterile conditions.
Which procedure does the company sterilizing an SPP apply?
Under Art. 22 (3), it applies one of the procedures in Annex IX or Annex XI Part A and draws up a declaration stating that sterilization has been carried out in accordance with the manufacturer's instructions.
What information is on the sterile packaging?
Under Annex I 23.3: an indication permitting the sterile packaging to be recognized, the declaration of sterile condition, the sterilization method, the name and address of the manufacturer, a description of the device, the date of manufacture, the time limit indication and an instruction directing to the instructions for use for damaged packaging.
How is the "Packaged sterile?" field selected in ÜTS?
If the device is placed on the market packaged sterile, "Yes" is selected. This information must be on the label and/or sales packaging and in the instructions for use.
Where is the information for a device the user will sterilize?
According to the guidance, the pre-use sterilization information is in the instructions for use; there is no requirement for it to be on the label and/or sales packaging. Annex I 23.4 (j) also requires appropriate sterilization instructions in the instructions for use.
For ÜTS registration of your medical device: Medical Device ÜTS Registration Consultancy
Sources



